ArticleClinical case reports2025
Delayed TSC Diagnosis Presenting as End-Stage Renal Disease With Renal and Hepatic Angiomyolipoma: Case Report and Review.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Delayed TSC Diagnosis Presenting as End-Stage Renal Disease With Renal and Hepatic Angiomyolipoma: Case Report and Review.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberous sclerosis complex (TSC) is a rare and complex autosomal dominant disease. Many patients with TSC may remain undiagnosed for years due to its widespread and heterogeneous clinical presentation, with only 1% of TSC patients developing end-stage renal disease (ESRD). This case report presents a 50-year-old woman newly diagnosed with TSC due to ESRD. She had facial lesions in childhood, was diagnosed with renal angiomyolipoma (AML) in adulthood, and her daughter died of TSC-related epilepsy, but she was not diagnosed with TSC until the age of 50 when admitted to a nephrology unit for renal dysfunction. Additionally, the patient had multiple rare concurrent lesions, including ESRD, pulmonary lymphangiomyomatosis (PLAM), renal AML, and hepatic AML. To raise clinicians' awareness of the coexistence of renal and pulmonary lesions in TSC, 47 rare TSC case reports were reviewed and their clinical features analyzed. This case and literature review highlight the overlapping spectrum of renal AML, PLAM, and TSC, underscoring the importance of a systemic diagnostic approach for patients with these lesions. Proactive investigation of TSC can facilitate early intervention and improve outcomes, particularly in preventing progression to ESRD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.